HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Brian Gibler Selected Research

N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)

7/2005Changes in cardiac troponin T measurements are associated with adverse cardiac events in patients with chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Brian Gibler Research Topics

Disease

51Acute Coronary Syndrome
01/2018 - 11/2002
22Hemorrhage
01/2019 - 10/2005
19Unstable Angina
12/2010 - 12/2002
17Myocardial Infarction
08/2009 - 02/2002
13ST Elevation Myocardial Infarction
01/2018 - 05/2007
10Chest Pain (Chest Pains)
04/2008 - 08/2002
8Non-ST Elevated Myocardial Infarction
09/2009 - 11/2003
8Heart Failure
08/2009 - 01/2003
8Cardiovascular Diseases (Cardiovascular Disease)
03/2009 - 11/2002
6Stroke (Strokes)
04/2010 - 03/2005
5Chronic Renal Insufficiency
03/2009 - 07/2005
4Infarction (Infarctions)
09/2008 - 12/2003
3Coronary Artery Disease (Coronary Atherosclerosis)
06/2011 - 09/2006
3Necrosis
02/2011 - 04/2005
2Wounds and Injuries (Trauma)
01/2019 - 12/2004
2Hypercholesterolemia
09/2009 - 04/2006
2Dyspnea (Shortness of Breath)
02/2009 - 01/2003
2Hypertension (High Blood Pressure)
09/2006 - 07/2006
1Thrombosis (Thrombus)
09/2009
1Pathologic Constriction (Stenosis)
09/2009
1Overweight
06/2009
1Body Weight (Weight, Body)
06/2009
1Thrombocytopenia (Thrombopenia)
05/2009
1Rupture
09/2008
1Obesity
09/2008
1Asthma (Bronchial Asthma)
01/2008
1Dyslipidemias (Dyslipidemia)
12/2006
1Coronary Disease (Coronary Heart Disease)
12/2006
1Ischemia
12/2006
1Renal Insufficiency (Renal Failure)
09/2006
1Hyperlipidemias (Hyperlipidemia)
09/2006
1Bundle-Branch Block (Fascicular Block)
03/2003

Drug/Important Bio-Agent (IBA)

11TroponinIBA
06/2011 - 01/2003
9Glycoproteins (Glycoprotein)IBA
12/2010 - 11/2003
9Biomarkers (Surrogate Marker)IBA
09/2009 - 08/2002
7Clopidogrel (Plavix)FDA Link
11/2008 - 04/2006
6Platelet Membrane Glycoprotein IIbIBA
12/2010 - 12/2002
5Heparin (Liquaemin)FDA LinkGeneric
03/2010 - 12/2005
5MB Form Creatine KinaseIBA
04/2007 - 04/2003
4LipidsIBA
06/2011 - 02/2005
4Troponin T (Troponin T1)IBA
09/2009 - 03/2003
4ORALIT (ORS)IBA
05/2009 - 09/2006
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2010 - 07/2006
3Enoxaparin (Lovenox)FDA LinkGeneric
03/2010 - 03/2008
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2010 - 12/2005
3Brain Natriuretic Peptide (Natrecor)FDA Link
02/2009 - 01/2003
3Eptifibatide (Integrilin)FDA Link
03/2008 - 12/2002
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2008 - 04/2006
3Creatine Kinase (Creatine Phosphokinase)IBA
12/2006 - 01/2003
3MyoglobinIBA
04/2003 - 09/2002
2Cocaine (Cocaine HCl)IBA
01/2012 - 04/2008
2oxidized low density lipoproteinIBA
12/2010 - 09/2009
2LDL CholesterolIBA
12/2010 - 09/2009
2Warfarin (Coumadin)FDA LinkGeneric
05/2008 - 02/2008
2trans-crotonin (CTN)IBA
03/2008 - 12/2006
2Indicators and Reagents (Reagents)IBA
08/2007 - 12/2002
2Troponin IIBA
04/2007 - 04/2003
2Platelet Membrane GlycoproteinsIBA
12/2003 - 11/2002
1Factor Xa InhibitorsIBA
01/2019
1Protein CIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Prothrombin (Factor II)IBA
01/2019
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2019
1AnticoagulantsIBA
01/2019
1Factor Xa (Coagulation Factor Xa)IBA
01/2019
1RivaroxabanIBA
01/2019
1PRT064445IBA
01/2019
1apixabanIBA
01/2019
1Complement System Proteins (Complement)IBA
04/2009
1HDL LipoproteinsIBA
10/2008
1HDL CholesterolIBA
10/2008
1AdipokinesIBA
09/2008
1Radioisotopes (Radionuclides)IBA
12/2007
1CholesterolIBA
12/2006
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2006
1AntithrombinsIBA
12/2005
1Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2005
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
07/2005
1Morphine (MS Contin)FDA LinkGeneric
06/2005
1Natriuretic PeptidesIBA
09/2004
1paragonIBA
04/2003
1Immunoglobulin A (IgA)IBA
12/2002

Therapy/Procedure

30Therapeutics
01/2019 - 07/2002
15Percutaneous Coronary Intervention
02/2012 - 03/2003
12Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2009 - 03/2003
4Contraindications
05/2010 - 05/2007
4Erythrocyte Transfusion
05/2009 - 03/2005
3Drug-Eluting Stents
09/2009 - 09/2005
3Length of Stay
03/2009 - 12/2005
3Thrombolytic Therapy
09/2008 - 02/2002
2Stents
09/2009 - 02/2008
1Critical Care (Surgical Intensive Care)
01/2019
1Anticoagulation Reversal
01/2019
1Continuity of Patient Care
01/2018
1Medication Errors (Medication Error)
04/2010
1Conservative Treatment
11/2009
1Patient Readmission
02/2009
1Nebulizers and Vaporizers (Inhaler)
01/2008
1Blood Transfusion (Blood Transfusions)
10/2005
1Airway Management
12/2004